Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Post by inviolablspiriton Dec 13, 2024 10:13am
83 Views
Post# 36360852

Private Placement

Private PlacementI knew something was up when I saw instinet show up, as they are brought in to execute trades for groups like hedge funds, mutual funds, insurance companies and pension funds.  I'm going to guess that they are here for a hedge fund possibly in the US.  This might explain the higher volume we saw over the last few days on the US side.   This private placement may actually be good news because to move this stock forward the company does need a stratigic investor like a hedge fund or institution.   Something with money behind it to help move it forward past the penny flippers.   I don't mind taking one step back to make two steps forward.   Clearly who ever it is, they wanted the same deal as the last private placement.   I think we have some very good news coming into the new year and beyond.  Any thoughts?
<< Previous
Bullboard Posts
Next >>